{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:36:18Z","timestamp":1791020178340,"version":"4.1.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"National Institute for Research on Metabolic and Cardiovascular Diseases","award":[". LX22NPO5104"],"award-info":[{"award-number":[". LX22NPO5104"]}]},{"name":"European Union Next-Generation EU and by the Ministry of Health of the Czech Republic","award":["NW24-09-00184"],"award-info":[{"award-number":["NW24-09-00184"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s40266-025-01234-0","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T17:40:51Z","timestamp":1754934051000},"page":"837-851","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Charcot foot disease: A new approach"],"prefix":"10.1007","volume":"42","author":[{"given":"Michal","family":"Dubsk\u00fd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"B\u00e9m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika","family":"Soj\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimira","family":"Fejfarov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3186-4122","authenticated-orcid":false,"given":"Edward B.","family":"Jude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"issue":"9","key":"1234_CR1","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.2337\/dc11-0844","volume":"34","author":"LC Rogers","year":"2011","unstructured":"Rogers LC, et al. The Charcot foot in diabetes. Diabetes Care. 2011;34(9):2123\u20139.","journal-title":"Diabetes Care"},{"issue":"5","key":"1234_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4239\/wjd.v2.i5.59","volume":"2","author":"E Gouveri","year":"2011","unstructured":"Gouveri E, Papanas N. Charcot osteoarthropathy in diabetes: a brief review with an emphasis on clinical practice. World J Diabetes. 2011;2(5):59\u201365.","journal-title":"World J Diabetes"},{"issue":"1","key":"1234_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13244-019-0768-9","volume":"10","author":"AB Rosskopf","year":"2019","unstructured":"Rosskopf AB, et al. The Charcot foot: a pictorial review. Insights Imaging. 2019;10(1):77.","journal-title":"Insights Imaging"},{"key":"1234_CR4","doi-asserted-by":"publisher","first-page":"21117","DOI":"10.3402\/dfa.v4i0.21117","volume":"4","author":"G Kaynak","year":"2013","unstructured":"Kaynak G, et al. An overview of the Charcot foot pathophysiology. Diabet Foot Ankle. 2013;4:21117.","journal-title":"Diabet Foot Ankle"},{"key":"1234_CR5","unstructured":"Northern Diabetes Foot Care Network. Active Charcot Foot Syndrome Guidelines. National Institute for Health and Clinical Excellence (2015). Diabetic foot problems and management. NICE guideline (ng19); 2019."},{"key":"1234_CR6","doi-asserted-by":"publisher","first-page":"3207043","DOI":"10.1155\/2016\/3207043","volume":"2016","author":"T Kucera","year":"2016","unstructured":"Kucera T, Shaikh HH, Sponer P. Charcot neuropathic arthropathy of the foot: a literature review and single-center experience. J Diabetes Res. 2016;2016:3207043.","journal-title":"J Diabetes Res"},{"key":"1234_CR7","first-page":"1","volume":"11","author":"Y Thewjitcharoen","year":"2018","unstructured":"Thewjitcharoen Y, et al. Salient features and outcomes of Charcot foot\u2014an often-overlooked diabetic complication: a 17-year-experience at a diabetic center in Bangkok. J Clin Transl Endocrinol. 2018;11:1\u20136.","journal-title":"J Clin Transl Endocrinol"},{"issue":"4","key":"1234_CR8","doi-asserted-by":"publisher","first-page":"114","DOI":"10.17161\/kjm.v11i4.8709","volume":"11","author":"ML Vopat","year":"2018","unstructured":"Vopat ML, et al. Initial diagnosis and management for acute Charcot neuroarthropathy. Kans J Med. 2018;11(4):114\u20139.","journal-title":"Kans J Med"},{"key":"1234_CR9","doi-asserted-by":"publisher","first-page":"21361","DOI":"10.3402\/dfa.v4i0.21361","volume":"4","author":"R Donegan","year":"2013","unstructured":"Donegan R, Sumpio B, Blume PA. Charcot foot and ankle with osteomyelitis. Diabet Foot Ankle. 2013;4:21361.","journal-title":"Diabet Foot Ankle"},{"issue":"9","key":"1234_CR10","first-page":"1591","volume":"64","author":"TC Sommer","year":"2001","unstructured":"Sommer TC, Lee TH. Charcot foot: the diagnostic dilemma. Am Fam Physician. 2001;64(9):1591\u20138.","journal-title":"Am Fam Physician"},{"key":"1234_CR11","doi-asserted-by":"publisher","first-page":"4275741","DOI":"10.1155\/jdr\/4275741","volume":"2025","author":"EB Jude","year":"2025","unstructured":"Jude EB, et al. Demographic and clinical characteristics of patients with Charcot neuro-osteoarthropathy in people with diabetes mellitus in six countries: a multicenter observational study from 1996 to 2022. J Diabetes Res. 2025;2025:4275741.","journal-title":"J Diabetes Res"},{"key":"1234_CR12","doi-asserted-by":"publisher","first-page":"20872","DOI":"10.3402\/dfa.v4i0.20872","volume":"4","author":"N Papanas","year":"2013","unstructured":"Papanas N, Maltezos E. Etiology, pathophysiology and classifications of the diabetic Charcot foot. Diabet Foot Ankle. 2013;4:20872.","journal-title":"Diabet Foot Ankle"},{"issue":"2","key":"1234_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jdiacomp.2007.04.004","volume":"22","author":"A Nather","year":"2008","unstructured":"Nather A, et al. Epidemiology of diabetic foot problems and predictive factors for limb loss. J Diabetes Complicat. 2008;22(2):77\u201382.","journal-title":"J Diabetes Complicat"},{"issue":"5","key":"1234_CR14","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1053\/j.jfas.2022.01.008","volume":"61","author":"GS Korst","year":"2022","unstructured":"Korst GS, et al. Delayed diagnosis of Charcot foot: a systematic review. J Foot Ankle Surg. 2022;61(5):1109\u201313.","journal-title":"J Foot Ankle Surg"},{"issue":"12","key":"1234_CR15","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1111\/j.1464-5491.2005.01677.x","volume":"22","author":"E Chantelau","year":"2005","unstructured":"Chantelau E. The perils of procrastination: effects of early vs. delayed detection and treatment of incipient Charcot fracture. Diabet Med. 2005;22(12):1707\u201312.","journal-title":"Diabet Med"},{"issue":"7","key":"1234_CR16","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.2337\/dc21-2508","volume":"45","author":"W Jeffcoate","year":"2022","unstructured":"Jeffcoate W, Game F. The Charcot foot reflects a response to injury that is critically distorted by preexisting nerve damage: an imperfect storm. Diabetes Care. 2022;45(7):1691\u20137.","journal-title":"Diabetes Care"},{"issue":"4","key":"1234_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.diabet.2010.04.002","volume":"36","author":"L Molines","year":"2010","unstructured":"Molines L, Darmon P, Raccah D. Charcot\u2019s foot: newest findings on its pathophysiology, diagnosis and treatment. Diabetes Metab. 2010;36(4):251\u20135.","journal-title":"Diabetes Metab"},{"issue":"3","key":"1234_CR18","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.3390\/ijms24033014","volume":"24","author":"T Greco","year":"2023","unstructured":"Greco T, et al. RANKL-RANK-OPG pathway in Charcot diabetic foot: pathophysiology and clinical-therapeutic implications. Int J Mol Sci. 2023;24(3):3014.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1234_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13047-022-00522-x","volume":"15","author":"SM Lanting","year":"2022","unstructured":"Lanting SM, et al. Cutaneous microvascular reactivity in Charcot neuroarthropathy: a systematic review and meta-analysis. J Foot Ankle Res. 2022;15(1):17.","journal-title":"J Foot Ankle Res"},{"issue":"5","key":"1234_CR20","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.mcna.2013.05.002","volume":"97","author":"JV Mascarenhas","year":"2013","unstructured":"Mascarenhas JV, Jude EB. Pathogenesis and medical management of diabetic Charcot neuroarthropathy. Med Clin N Am. 2013;97(5):857\u201372.","journal-title":"Med Clin N Am"},{"issue":"4","key":"1234_CR21","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00592-020-01638-x","volume":"58","author":"R Ochoa-Precoma","year":"2021","unstructured":"Ochoa-Precoma R, et al. Association between osteoprotegerin and Charcot neuroarthropathy: a systematic review. Acta Diabetol. 2021;58(4):475\u201384.","journal-title":"Acta Diabetol"},{"issue":"10","key":"1234_CR22","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1177\/10711007241268147","volume":"45","author":"A Rastogi","year":"2024","unstructured":"Rastogi A, et al. Anti-RANKL antibody for active Charcot foot neuro-osteoarthropathy in patients with diabetes and chronic kidney disease. Foot Ankle Int. 2024;45(10):1122\u201330.","journal-title":"Foot Ankle Int"},{"issue":"4","key":"1234_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3109\/17453674.2015.1033606","volume":"86","author":"A Folestad","year":"2015","unstructured":"Folestad A, et al. Role of Wnt\/beta-catenin and RANKL\/OPG in bone healing of diabetic Charcot arthropathy patients. Acta Orthop. 2015;86(4):415\u201325.","journal-title":"Acta Orthop"},{"issue":"10","key":"1234_CR24","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1210\/js.2019-00160","volume":"3","author":"K Asadipooya","year":"2019","unstructured":"Asadipooya K, Uy EM. Advanced glycation end products (AGEs), receptor for AGEs, diabetes, and bone: review of the literature. J Endocr Soc. 2019;3(10):1799\u2013818.","journal-title":"J Endocr Soc"},{"key":"1234_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2024.117301","volume":"190","author":"D Vashishth","year":"2025","unstructured":"Vashishth D, Dhaliwal R, Rubin M. AGEs (advanced glycation end-products) in bone come of age. Bone. 2025;190: 117301.","journal-title":"Bone"},{"issue":"4","key":"1234_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.14341\/probl13362","volume":"70","author":"MV Yaroslavceva","year":"2024","unstructured":"Yaroslavceva MV, et al. Etiopathogenetic features of bone metabolism in patients with diabetes mellitus and Charcot foot. Probl Endokrinol (Mosk). 2024;70(4):57\u201364.","journal-title":"Probl Endokrinol (Mosk)"},{"key":"1234_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108337","volume":"166","author":"A Kloska","year":"2020","unstructured":"Kloska A, et al. The role of genetic factors and monocyte-to-osteoclast differentiation in the pathogenesis of Charcot neuroarthropathy. Diabetes Res Clin Pract. 2020;166: 108337.","journal-title":"Diabetes Res Clin Pract"},{"key":"1234_CR28","doi-asserted-by":"crossref","unstructured":"Sharma S, Rastogi A. Genetic signature for the causation of Charcot neuro-osteoarthropathy of foot in diabetes: a systematic review. Int J Low Extrem Wounds. 2024:15347346241252549.","DOI":"10.1177\/15347346241252549"},{"issue":"3","key":"1234_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3646","volume":"40","author":"DK Wukich","year":"2024","unstructured":"Wukich DK, et al. Guidelines on the diagnosis and treatment of active Charcot neuro-osteoarthropathy in persons with diabetes mellitus (IWGDF 2023). Diabetes Metab Res Rev. 2024;40(3): e3646.","journal-title":"Diabetes Metab Res Rev"},{"key":"1234_CR30","doi-asserted-by":"crossref","unstructured":"Bus SA et al. Effectiveness of at-home skin temperature monitoring in reducing the incidence of foot ulcer recurrence in people with diabetes: a multicenter randomized controlled trial (DIATEMP). BMJ Open Diabetes Res Care. 2021:9(1).","DOI":"10.1136\/bmjdrc-2021-002392"},{"issue":"9","key":"1234_CR31","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00592-023-02101-3","volume":"60","author":"CA Julien","year":"2023","unstructured":"Julien CA, et al. Real-world treatment patterns and diagnosis of Charcot foot in Franco-Belgian diabetic foot expert centers (The EPiChar Study). Acta Diabetol. 2023;60(9):1209\u201318.","journal-title":"Acta Diabetol"},{"issue":"12","key":"1234_CR32","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.2174\/1381612824666180227094116","volume":"24","author":"C Lauri","year":"2018","unstructured":"Lauri C, Glaudemans A, Signore A. Leukocyte imaging of the diabetic foot. Curr Pharm Des. 2018;24(12):1270\u20136.","journal-title":"Curr Pharm Des"},{"issue":"2","key":"1234_CR33","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1177\/10711007231213645","volume":"45","author":"S Dharmadas","year":"2024","unstructured":"Dharmadas S, et al. Biomarkers for early detection of Charcot arthropathy: a prospective study on type 2 diabetes patients with severe neuropathy. Foot Ankle Int. 2024;45(2):175\u20138.","journal-title":"Foot Ankle Int"},{"key":"1234_CR34","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2014.13948","volume":"144","author":"EA Chantelau","year":"2014","unstructured":"Chantelau EA, Grutzner G. Is the Eichenholtz classification still valid for the diabetic Charcot foot? Swiss Med Wkly. 2014;144: w13948.","journal-title":"Swiss Med Wkly"},{"issue":"3","key":"1234_CR35","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1007\/s11999-014-4059-y","volume":"473","author":"AJ Rosenbaum","year":"2015","unstructured":"Rosenbaum AJ, DiPreta JA. Classifications in brief: Eichenholtz classification of Charcot arthropathy. Clin Orthop Relat Res. 2015;473(3):1168\u201371.","journal-title":"Clin Orthop Relat Res"},{"key":"1234_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40842-015-0018-0","volume":"1","author":"C Holmes","year":"2015","unstructured":"Holmes C, et al. Charcot stage 0: a review and consideratons for making the correct diagnosis early. Clin Diabetes Endocrinol. 2015;1:18.","journal-title":"Clin Diabetes Endocrinol"},{"issue":"3","key":"1234_CR37","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1053\/j.jfas.2020.03.003","volume":"60","author":"DK Wukich","year":"2021","unstructured":"Wukich DK, et al. Are the Sanders\u2013Frykberg and Brodsky\u2013Trepman classifications reliable in diabetic charcot neuroarthropathy? J Foot Ankle Surg. 2021;60(3):432\u20135.","journal-title":"J Foot Ankle Surg"},{"issue":"1","key":"1234_CR38","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1177\/107110070502600109","volume":"26","author":"E Trepman","year":"2005","unstructured":"Trepman E, Nihal A, Pinzur MS. Current topics review: Charcot neuroarthropathy of the foot and ankle. Foot Ankle Int. 2005;26(1):46\u201363.","journal-title":"Foot Ankle Int"},{"key":"1234_CR39","doi-asserted-by":"publisher","first-page":"1344359","DOI":"10.3389\/fcdhc.2024.1344359","volume":"5","author":"M Argyropoulos","year":"2024","unstructured":"Argyropoulos M, et al. Charcot neuro-osteoarthropathy: a review of key concepts and an evidence-based surgical management algorithm. Front Clin Diabetes Healthc. 2024;5:1344359.","journal-title":"Front Clin Diabetes Healthc"},{"issue":"1","key":"1234_CR40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/(SICI)1096-9136(199701)14:1<46::AID-DIA291>3.0.CO;2-T","volume":"14","author":"LA Lavery","year":"1997","unstructured":"Lavery LA, Armstrong DG, Walker SC. Healing rates of diabetic foot ulcers associated with midfoot fracture due to Charcot\u2019s arthropathy. Diabet Med. 1997;14(1):46\u20139.","journal-title":"Diabet Med"},{"issue":"2","key":"1234_CR41","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.dsx.2019.01.008","volume":"13","author":"AP Sebastian","year":"2019","unstructured":"Sebastian AP, et al. Clinical features, radiological characteristics and offloading modalities in stage 0 acute Charcot\u2019s neuroarthropathy\u2014a single centre experience from South India. Diabetes Metab Syndr. 2019;13(2):1081\u20135.","journal-title":"Diabetes Metab Syndr"},{"issue":"5","key":"1234_CR42","doi-asserted-by":"publisher","first-page":"E513","DOI":"10.1503\/cjs.006022","volume":"66","author":"TM Huynh","year":"2023","unstructured":"Huynh TM, et al. Charcot arthropathy outcomes after early referral to a regional tertiary care foot clinic. Can J Surg. 2023;66(5):E513\u20139.","journal-title":"Can J Surg"},{"issue":"1","key":"1234_CR43","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13047-021-00477-5","volume":"14","author":"DA Griffiths","year":"2021","unstructured":"Griffiths DA, Kaminski MR. Duration of total contact casting for resolution of acute Charcot foot: a retrospective cohort study. J Foot Ankle Res. 2021;14(1):44.","journal-title":"J Foot Ankle Res"},{"key":"1234_CR44","doi-asserted-by":"publisher","first-page":"5945839","DOI":"10.1155\/2019\/5945839","volume":"2019","author":"V Fejfarova","year":"2019","unstructured":"Fejfarova V, et al. The superiority of removable contact splints in the healing of diabetic foot during postoperative care. J Diabetes Res. 2019;2019:5945839.","journal-title":"J Diabetes Res"},{"issue":"12","key":"1234_CR45","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1177\/107110079701801210","volume":"18","author":"JE Shaw","year":"1997","unstructured":"Shaw JE, et al. The mechanism of plantar unloading in total contact casts: implications for design and clinical use. Foot Ankle Int. 1997;18(12):809\u201317.","journal-title":"Foot Ankle Int"},{"issue":"3","key":"1234_CR46","first-page":"205","volume":"32","author":"JJ Wertsch","year":"1995","unstructured":"Wertsch JJ, et al. Plantar pressures with total contact casting. J Rehabil Res Dev. 1995;32(3):205\u20139.","journal-title":"J Rehabil Res Dev"},{"issue":"3","key":"1234_CR47","doi-asserted-by":"publisher","first-page":"586","DOI":"10.2337\/dc06-1750","volume":"30","author":"A Piaggesi","year":"2007","unstructured":"Piaggesi A, et al. An off-the-shelf instant contact casting device for the management of diabetic foot ulcers: a randomized prospective trial versus traditional fiberglass cast. Diabetes Care. 2007;30(3):586\u201390.","journal-title":"Diabetes Care"},{"issue":"1","key":"1234_CR48","doi-asserted-by":"publisher","first-page":"247301142513156","DOI":"10.1177\/24730114251315670","volume":"10","author":"T Berhane","year":"2025","unstructured":"Berhane T, et al. Offloading interventions for the management of Charcot neuroarthropathy in diabetes. Foot Ankle Orthop. 2025;10(1):24730114251315670.","journal-title":"Foot Ankle Orthop"},{"key":"1234_CR49","doi-asserted-by":"publisher","first-page":"205031212413069","DOI":"10.1177\/20503121241306957","volume":"12","author":"R Prem","year":"2024","unstructured":"Prem R, et al. Weight bearing versus non-weight bearing total contact cast in the management of active Charcot foot: a systematic review. SAGE Open Med. 2024;12:20503121241306956.","journal-title":"SAGE Open Med"},{"issue":"8","key":"1234_CR50","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1177\/1071100716643429","volume":"37","author":"A Piaggesi","year":"2016","unstructured":"Piaggesi A, et al. Comparison of removable and irremovable walking boot to total contact casting in offloading the neuropathic diabetic foot ulceration. Foot Ankle Int. 2016;37(8):855\u201361.","journal-title":"Foot Ankle Int"},{"key":"1234_CR51","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13047-021-00477-5","volume":"14","author":"DA Griffiths","year":"2021","unstructured":"Griffiths DA, Kaminski MR. Duration of total contact casting for resolution of acute Charcot foot: a retrospective cohort study. J Foot Ankle Res. 2021;14:44.","journal-title":"J Foot Ankle Res"},{"issue":"9","key":"1234_CR52","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1177\/107110079801900909","volume":"19","author":"JA Mehta","year":"1998","unstructured":"Mehta JA, Brown C, Sargeant N. Charcot restraint orthotic walker. Foot Ankle Int. 1998;19(9):619\u201323.","journal-title":"Foot Ankle Int"},{"issue":"10","key":"1234_CR53","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1007\/s00402-021-03881-5","volume":"142","author":"V Gratwohl","year":"2022","unstructured":"Gratwohl V, et al. Long-term follow-up of conservative treatment of Charcot feet. Arch Orthop Trauma Surg. 2022;142(10):2553\u201366.","journal-title":"Arch Orthop Trauma Surg"},{"issue":"2","key":"1234_CR54","doi-asserted-by":"publisher","first-page":"252","DOI":"10.2337\/dc23-1063","volume":"47","author":"J Schoug","year":"2024","unstructured":"Schoug J, et al. Charcot foot offloading in stage 0 is associated with shorter total contact cast treatment and lower risk of recurrence and reconstructive surgery: a pilot study. Diabetes Care. 2024;47(2):252\u20138.","journal-title":"Diabetes Care"},{"issue":"9","key":"1234_CR55","first-page":"988","volume":"21","author":"V Fejfarova","year":"2005","unstructured":"Fejfarova V, Jirkovska A, Krizova M, Skiboja J. The effect of removable total contact cast therapy on healing of patients with diabetic foot ulcers, acute Charcot osteoarthropathy and neuropathic fractures. Vnitr Lek. 2005;21(9):988\u201394.","journal-title":"Vnitr Lek"},{"issue":"12","key":"1234_CR56","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.3390\/medicina58121763","volume":"58","author":"T Benard","year":"2022","unstructured":"Benard T, et al. Delayed diagnosis of bilateral neuroarthropathy: serious impact on the development of Charcot\u2019s foot, a case report. Medicina (Kaunas). 2022;58(12):1763.","journal-title":"Medicina (Kaunas)"},{"issue":"6","key":"1234_CR57","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00592-020-01664-9","volume":"58","author":"A Rastogi","year":"2021","unstructured":"Rastogi A, Bhansali A, Jude EB. Efficacy of medical treatment for Charcot neuroarthropathy: a systematic review and meta-analysis of randomized controlled trials. Acta Diabetol. 2021;58(6):687\u201396.","journal-title":"Acta Diabetol"},{"issue":"5","key":"1234_CR58","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S1056-8727(98)00006-3","volume":"12","author":"DR Sinacore","year":"1998","unstructured":"Sinacore DR. Acute Charcot arthropathy in patients with diabetes mellitus: healing times by foot location. J Diabetes Complicat. 1998;12(5):287\u201393.","journal-title":"J Diabetes Complicat"},{"issue":"6","key":"1234_CR59","doi-asserted-by":"publisher","first-page":"206","DOI":"10.25270\/wnds\/24029","volume":"36","author":"GM Rothenberg","year":"2024","unstructured":"Rothenberg GM, Killeen AL, Holmes C. Reviewing recommendations from the IWGDF 2023 guidelines on the diagnosis and treatment of active Charcot neuro-osteoarthropathy: highlighting the role of temperature monitoring with illustrative case reports. Wounds. 2024;36(6):206\u201311.","journal-title":"Wounds"},{"issue":"6","key":"1234_CR60","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.2337\/dc06-0376","volume":"29","author":"R Bem","year":"2006","unstructured":"Bem R, et al. Intranasal calcitonin in the treatment of acute Charcot neuroosteoarthropathy: a randomized controlled trial. Diabetes Care. 2006;29(6):1392\u20134.","journal-title":"Diabetes Care"},{"issue":"11","key":"1234_CR61","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1007\/s001250100008","volume":"44","author":"EB Jude","year":"2001","unstructured":"Jude EB, et al. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia. 2001;44(11):2032\u20137.","journal-title":"Diabetologia"},{"issue":"2","key":"1234_CR62","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1053\/j.jfas.2020.09.018","volume":"60","author":"D Shofler","year":"2021","unstructured":"Shofler D, et al. Investigating the use of denosumab in the treatment of acute Charcot neuroarthropathy. J Foot Ankle Surg. 2021;60(2):354\u20137.","journal-title":"J Foot Ankle Surg"},{"issue":"3","key":"1234_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3653","volume":"40","author":"KM Raspovic","year":"2024","unstructured":"Raspovic KM, et al. Diagnosis and treatment of active Charcot neuro-osteoarthropathy in persons with diabetes mellitus: a systematic review. Diabetes Metab Res Rev. 2024;40(3): e3653.","journal-title":"Diabetes Metab Res Rev"},{"issue":"11","key":"1234_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0259224","volume":"16","author":"L Das","year":"2021","unstructured":"Das L, et al. Long-term foot outcomes following differential abatement of inflammation and osteoclastogenesis for active Charcot neuroarthropathy in diabetes mellitus. PLoS ONE. 2021;16(11): e0259224.","journal-title":"PLoS ONE"},{"key":"1234_CR65","doi-asserted-by":"crossref","unstructured":"Kobayakawa T. Sequential and combination therapy with romosozumab. J Bone Miner Metab. 2025.","DOI":"10.1007\/s00774-025-01590-2"},{"issue":"33","key":"1234_CR66","doi-asserted-by":"publisher","first-page":"13998","DOI":"10.1073\/pnas.0810087106","volume":"106","author":"JA Ehses","year":"2009","unstructured":"Ehses JA, et al. IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat. Proc Natl Acad Sci USA. 2009;106(33):13998\u20134003.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1234_CR67","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/917945","volume":"2015","author":"NL Petrova","year":"2015","unstructured":"Petrova NL, et al. Inhibition of TNF-alpha reverses the pathological resorption pit profile of osteoclasts from patients with acute Charcot osteoarthropathy. J Diabetes Res. 2015;2015: 917945.","journal-title":"J Diabetes Res"},{"issue":"12","key":"1234_CR68","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.3390\/biomedicines12122775","volume":"12","author":"F Farine","year":"2024","unstructured":"Farine F, et al. Predictive factors of amputation in diabetic foot. Biomedicines. 2024;12(12):2775.","journal-title":"Biomedicines"},{"key":"1234_CR69","doi-asserted-by":"publisher","first-page":"26627","DOI":"10.3402\/dfa.v6.26627","volume":"6","author":"VL Schade","year":"2015","unstructured":"Schade VL, Andersen CA. A literature-based guide to the conservative and surgical management of the acute Charcot foot and ankle. Diabet Foot Ankle. 2015;6:26627.","journal-title":"Diabet Foot Ankle"},{"key":"1234_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcot.2023.102317","volume":"47","author":"O Khan","year":"2023","unstructured":"Khan O, et al. Surgical management of Charcot foot\u2014the advancements over the past decade. J Clin Orthop Trauma. 2023;47: 102317.","journal-title":"J Clin Orthop Trauma"},{"issue":"9","key":"1234_CR71","first-page":"4","volume":"29","author":"CY Tan","year":"2024","unstructured":"Tan CY, Xi KCC. Surgical timing for Charcot foot reconstruction: pattern of paradigm shift from a systematic review of recent literature. Foot Ankle Orthop. 2024;29(9):4.","journal-title":"Foot Ankle Orthop"},{"key":"1234_CR72","unstructured":"Bitton RR, T N. Surgical timing for Charcot foot reconstruction: outcomes after active and inactive stage intervention. Foot Ankle Orthop. 2024:9(4)."},{"issue":"3","key":"1234_CR73","doi-asserted-by":"publisher","first-page":"247301142311881","DOI":"10.1177\/24730114231188128","volume":"8","author":"MS Pinzur","year":"2023","unstructured":"Pinzur MS. Republication of \u201can evidence-based introduction to Charcot foot arthropathy.\u201d Foot Ankle Orthop. 2023;8(3):24730114231188130.","journal-title":"Foot Ankle Orthop"},{"issue":"4","key":"1234_CR74","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.fas.2009.02.005","volume":"15","author":"TK Pakarinen","year":"2009","unstructured":"Pakarinen TK, et al. Long-term outcome and quality of life in patients with Charcot foot. Foot Ankle Surg. 2009;15(4):187\u201391.","journal-title":"Foot Ankle Surg"},{"key":"1234_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcot.2021.101637","volume":"23","author":"B Rana","year":"2021","unstructured":"Rana B, Patel S. Results of Ankle and Hind foot arthrodesis in diabetic Charcot neuroarthropathy\u2014a retrospective analysis of 44 patients. J Clin Orthop Trauma. 2021;23: 101637.","journal-title":"J Clin Orthop Trauma"},{"issue":"Supp 4","key":"1234_CR76","first-page":"190","volume":"88","author":"EN Kubiak","year":"2006","unstructured":"Kubiak EN. The evolution of locked plates. J Bone Jt Surg Am. 2006;88(Supp 4):190\u2013203.","journal-title":"J Bone Jt Surg Am"},{"issue":"1","key":"1234_CR77","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5704\/MOJ.2303.004","volume":"17","author":"SL Ong","year":"2023","unstructured":"Ong SL, Bajuri MY, Mazli N. Outcome of surgical fixation for midfoot Charcot neuroarthropathy\u2014a systematic review. Malays Orthop J. 2023;17(1):27\u201333.","journal-title":"Malays Orthop J"},{"issue":"4","key":"1234_CR78","doi-asserted-by":"publisher","first-page":"e595","DOI":"10.3928\/01477447-20160526-11","volume":"39","author":"DJ Lee","year":"2016","unstructured":"Lee DJ, et al. Internal versus external fixation of Charcot midfoot deformity realignment. Orthopedics. 2016;39(4):e595-601.","journal-title":"Orthopedics"},{"issue":"1","key":"1234_CR79","first-page":"34","volume":"1","author":"P Poulios","year":"2021","unstructured":"Poulios P, Bhargava A, Mallick A, Tiruveedhula M. Current concepts in the surgical treatment of Charcot foot arthropathy: a scoping review of the literature. SVOA Orthop. 2021;1(1):34\u20138.","journal-title":"SVOA Orthop"},{"issue":"3","key":"1234_CR80","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.fcl.2004.05.010","volume":"9","author":"SA Herbst","year":"2004","unstructured":"Herbst SA. External fixation of Charcot arthropathy. Foot Ankle Clin. 2004;9(3):595\u2013609.","journal-title":"Foot Ankle Clin"},{"issue":"4","key":"1234_CR81","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cpm.2022.05.007","volume":"39","author":"W Grant","year":"2022","unstructured":"Grant W, Grant-McDonald L. Beaming the Charcot foot. Clin Podiatr Med Surg. 2022;39(4):605\u201327.","journal-title":"Clin Podiatr Med Surg"},{"issue":"6","key":"1234_CR82","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1177\/10711007221077113","volume":"43","author":"B Abar","year":"2022","unstructured":"Abar B, et al. Outcomes of surgical reconstruction using custom 3D-printed porous titanium implants for critical-sized bone defects of the foot and ankle. Foot Ankle Int. 2022;43(6):750\u201361.","journal-title":"Foot Ankle Int"},{"issue":"4","key":"1234_CR83","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1053\/j.jfas.2019.06.008","volume":"59","author":"P Wrotslavsky","year":"2020","unstructured":"Wrotslavsky P, et al. Computer-assisted gradual correction of Charcot foot deformities: an in-depth evaluation of stage one of a planned two-stage approach to Charcot reconstruction. J Foot Ankle Surg. 2020;59(4):841\u20138.","journal-title":"J Foot Ankle Surg"},{"issue":"3","key":"1234_CR84","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1053\/j.jfas.2015.04.016","volume":"55","author":"KW Hegewald","year":"2016","unstructured":"Hegewald KW, et al. Combined internal and external fixation for diabetic Charcot reconstruction: a retrospective case series. J Foot Ankle Surg. 2016;55(3):619\u201327.","journal-title":"J Foot Ankle Surg"},{"key":"1234_CR85","doi-asserted-by":"crossref","unstructured":"Iqbal MH, Qasim S, Chambers S. Combined internal and external fixation for Charcot neuro arthropathy: 1 year results. Foot Ankle Orthop. 2022;7(4).","DOI":"10.1177\/2473011421S00704"},{"key":"1234_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.820826","volume":"9","author":"MY Bajuri","year":"2022","unstructured":"Bajuri MY, et al. Charcot neuroarthropathy: current surgical management and update. A systematic review. Front Surg. 2022;9: 820826.","journal-title":"Front Surg"},{"issue":"12","key":"1234_CR87","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.jdiacomp.2018.09.013","volume":"32","author":"RB Jansen","year":"2018","unstructured":"Jansen RB, et al. Mortality and complications after treatment of acute diabetic Charcot foot. J Diabetes Complicat. 2018;32(12):1141\u20137.","journal-title":"J Diabetes Complicat"}],"container-title":["Drugs &amp; Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-025-01234-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-025-01234-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-025-01234-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T09:04:30Z","timestamp":1757927070000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-025-01234-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":87,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1234"],"URL":"https:\/\/doi.org\/10.1007\/s40266-025-01234-0","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"8 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Supported by the National Institute for Research on Metabolic and Cardiovascular Diseases (Programme EXCELES, Project No. LX22NPO5104), funded by the European Union Next-Generation EU and by the Ministry of Health of the Czech Republic NW24-09-00184.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"None of the authors (Dubsk\u00fd M, B\u00e9m R, Soj\u00e1kov\u00e1, Fejfarov\u00e1 V, Hughes M, Jude EB) have any conflicts to report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent (participation and publication)"}},{"value":"Data sharing not applicable to this article as no datasets were generated or analysed during the current study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability statement"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"M.D. wrote the manuscript, R.B. wrote pathogenesis and pharmacotherapy and carried out visualization; D.S. carried out visualization and edited the manuscript; V.F. wrote offloading, edited the manuscript; M.H. edited the manuscript; E. J. edited and supervised the manuscript.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}